News from h3 biomedicine inc

May 22, 2014, 11:15 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration

CAMBRIDGE, Mass. and KRAKOW, Poland, May 22, 2014 /PRNewswire/-- H3 Biomedicine Inc., a biopharmaceutical company specializing in the...

Apr 03, 2014, 09:08 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine's First Lead Candidate Program Targets Novel Genetic Mutations Involved in Multiple Cancers

H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision medicines for oncology, announced today...

Sep 16, 2013, 11:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine and Selvita Announce Strategic Collaboration to Develop Precision Cancer Medicines

 H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision oncology treatments, and Selvita...

Mar 21, 2013, 08:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data

 H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of oncology treatments, and BGI, the largest...

Dec 19, 2012, 08:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine Announces Strategic Collaboration with Sage Bionetworks to Advance Cancer-Genomics Research

 H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of oncology treatments, announced today that...

Nov 26, 2012, 08:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances

Following a productive first year of headcount growth and scientific advancement, H3 Biomedicine Inc. (H3), a biopharmaceutical company...

Oct 04, 2012, 08:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

Horizon Discovery Launches SyntheTx Partnership Program to Identify Novel Targets for Cancer Therapeutics

 Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, and H3...

Apr 30, 2012, 08:30 ET
H3 Biomedicine Inc.  (PRNewsFoto/H3 Biomedicine Inc.)

Horizon Discovery and H3 Biomedicine Collaborate to Identify and Validate Novel, Patient-Relevant Cancer Targets

 Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, and H3...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer